Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Special items of operating revenue | 144.45%7.35B | 188.54%5.31B | 299.70%2.04B | -3.89%4.21B | -12.74%3.01B | -27.01%1.84B | -48.25%510.37M | 11.59%4.39B | 19.87%3.44B | 29.61%2.52B |
| Operating income | 144.45%7.35B | 188.54%5.31B | 299.70%2.04B | -3.89%4.21B | -12.74%3.01B | -27.01%1.84B | -48.25%510.37M | 11.59%4.39B | 19.87%3.44B | 29.61%2.52B |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Administrative expenses | -143.28%-3.81B | ---- | -128.02%-1.07B | ---- | 3.60%-1.56B | ---- | -18.62%-470M | ---- | -31.77%-1.62B | ---- |
| Employee expense | ---- | -196.44%-1.88B | ---- | -3.27%-1.42B | ---- | 12.60%-633.13M | ---- | -24.57%-1.38B | ---- | -44.75%-724.45M |
| Depreciation and amortization | ---- | -46.19%-223.35M | ---- | -13.20%-306.24M | ---- | -28.73%-152.79M | ---- | -40.91%-270.53M | ---- | -28.30%-118.69M |
| Impairment and provision | 154.73%50.34M | 2,685.19%34.98M | 24,386.50%23.12M | -28.47%20.46M | -9.41%19.76M | -85.55%1.26M | -94.18%94.44K | 1,175.92%28.6M | 382.43%21.81M | 13.75%8.7M |
| -Other impairment is provision | 154.73%50.34M | 2,685.19%34.98M | 24,386.50%23.12M | -28.47%20.46M | -9.41%19.76M | -85.55%1.26M | -94.18%94.44K | 1,175.92%28.6M | 382.43%21.81M | 13.75%8.7M |
| Operating interest expense | -30.79%-1.31B | -35.20%-907.71M | -41.70%-477.46M | -5.82%-1.32B | -6.78%-1B | -11.68%-671.38M | -9.43%-336.95M | ---1.25B | -14.46%-937.08M | -10.98%-601.16M |
| Special items of operating profit | ---1.35M | -172.26%-929.68M | ---431.21K | -21.32%-814.4M | ---- | -0.58%-341.47M | ---- | -17.64%-671.3M | ---- | -18.40%-339.51M |
| Operating profit | 398.37%2.23B | 3,193.23%1.41B | 265.51%496.65M | -56.14%371.22M | -49.73%448.04M | -94.27%42.73M | -208.01%-300.07M | -58.90%846.44M | 11.20%891.19M | 40.41%746.13M |
| Share of profits of associates | ---- | 16.15%1.88M | ---- | 107.56%1.59M | ---- | 216.24%1.62M | ---- | -243.84%-21.03M | ---- | -90.37%511K |
| Special items of earning before tax | ---- | -160.16%-6.13M | ---- | ---- | ---- | -17.29%10.19M | ---- | ---- | ---- | 37.80%12.31M |
| Adjustment items of earning before tax | -528.79%-18.63M | ---- | -1,443.60%-8.9M | ---- | 7,097.79%4.34M | ---- | 565.84%662.48K | ---- | -98.05%60.35K | ---- |
| Earning before tax | 389.47%2.21B | 2,472.75%1.4B | 262.91%487.75M | -54.83%372.81M | -49.24%452.38M | -92.82%54.53M | -207.73%-299.41M | -14.50%825.42M | 10.78%891.26M | 39.09%758.96M |
| Tax | -761.37%-435.17M | -837.63%-266.21M | -231.61%-108.92M | 122.16%33.43M | 69.48%-50.52M | 122.85%36.09M | 217.28%82.76M | 23.86%-150.87M | -2.83%-165.55M | -45.66%-157.92M |
| After-tax profit from continuing operations | 342.72%1.78B | 1,154.39%1.14B | 274.86%378.83M | -39.78%406.23M | -44.62%401.86M | -84.92%90.62M | -204.49%-216.65M | -12.09%674.55M | 12.77%725.7M | 37.46%601.04M |
| Earning after tax | 342.72%1.78B | 1,154.39%1.14B | 274.86%378.83M | -39.78%406.23M | -44.62%401.86M | -84.92%90.62M | -204.49%-216.65M | -12.09%674.55M | 12.77%725.7M | 37.46%601.04M |
| Minority profit | 172.55%16.38M | 226.30%9.51M | 27.56%2.69M | 172.83%8.82M | 656.55%6.01M | 298.50%2.91M | --2.11M | --3.23M | ---1.08M | --731K |
| Profit attributable to shareholders | 345.30%1.76B | 1,185.21%1.13B | 271.95%376.14M | -40.80%397.42M | -45.53%395.85M | -85.39%87.71M | -205.50%-218.75M | -12.51%671.32M | 12.94%726.78M | 37.30%600.31M |
| Basic earnings per share | 121.43%0.31 | 566.67%0.2 | 200.00%0.08 | -41.67%0.14 | -46.15%0.14 | -85.71%0.03 | -214.29%-0.08 | -11.11%0.24 | 13.04%0.26 | 40.00%0.21 |
| Diluted earnings per share | 121.43%0.31 | 200.00%0.08 | -46.15%0.14 | -214.29%-0.08 | 13.04%0.26 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.